Artificial Hip and Knee Joints Market Size, Share and Growth Outlook, 2026

Artificial Hip and Knee Joints Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Artificial Hip and Knee Joints Market size is forecast to increase from $15.52 Billion in 2026 to $19.36 Billion in 2034 at a CAGR of 2.8% between 2026 and 2034.

The Artificial Hip and Knee Joints market report provides detailed analysis and outlook of Artificial Hip and Knee Joints segments including By Product (Knee Reconstructive Implants, Hip Reconstructive Implants), By Procedure (Total Joint Arthroplasty, Partial / Hemi-Arthroplasty, Revision Joint Arthroplasty, Cemented Fixation Systems, Cementless / Press-Fit Fixation Systems), By Material & Bearing Surface (Ceramic-on-Polyethylene, Ceramic-on-Ceramic, Metal-on-Polyethylene, 3D-Printed Porous Titanium / Metallic Scaffolds), By Surgical Approach (Traditional Open Joint Surgery, Minimally Invasive Surgery, Robotic-Assisted Surgery), By End-User (Hospitals & Tertiary Surgery Centers, Ambulatory Surgical Centers, Orthopedic Clinics & Private Practices) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Artificial Hip and Knee Joints Industry Overview

Robotic-Assisted Arthroplasty Is Transforming Joint Replacement Procedures

The artificial hip and knee joints industry is undergoing a significant technological transformation driven by advancements in robotic-assisted surgery, personalized implant planning, and next-generation fixation technologies. Healthcare providers are increasingly adopting digital orthopedic solutions that improve surgical precision, procedural consistency, and long-term patient outcomes. The growing emphasis on personalized joint reconstruction, minimally invasive surgical approaches, and data-driven treatment planning is encouraging manufacturers to expand robotic ecosystems and integrate advanced software capabilities into arthroplasty workflows. These innovations are helping surgeons optimize implant placement while supporting enhanced recovery and improved functional performance following joint replacement procedures.

Expansion of Robotic Surgery Platforms Strengthens Orthopedic Innovation

Robotic-assisted technology remains one of the most influential trends shaping the artificial hip and knee joints market. Zimmer Biomet expanded its ROSA® Robotics portfolio through the launch of the ROSA Shoulder System following FDA 510(k) clearance. This development completes the company’s robotic-assisted surgery ecosystem, which now supports hip, knee, and shoulder arthroplasty procedures. The integrated platform is designed to improve procedural consistency across both hospital and ambulatory surgical settings while providing surgeons with enhanced intraoperative guidance. Stryker further strengthened the robotic surgery segment through the introduction of Mako Patient Specific Hip, a software enhancement for its Mako SmartRobotics system. The platform enables pre-operative planning based on patient-specific three-dimensional anatomy, allowing surgeons to optimize implant positioning and improve soft-tissue balancing during total hip arthroplasty procedures. To support rising global demand for robotic-assisted orthopedic surgery, Stryker also expanded manufacturing capacity at its Limerick, Ireland facility, increasing production of Mako robotic arm systems.

Clinical Evidence Supports Long-Term Performance of Cementless Implants

Clinical research continues to influence implant selection and fixation strategies within the orthopedic reconstruction market. A multicenter study published in The Journal of Bone and Joint Surgery evaluated ten-year outcomes for cementless total knee arthroplasty utilizing porous titanium implant technology. The findings demonstrated survivorship rates comparable to conventional cemented total knee arthroplasty while delivering significant improvements in patient-reported outcome measures related to long-term knee function. These results support the growing adoption of cementless fixation approaches, particularly as implant manufacturers continue to enhance porous surface technologies that promote biological fixation and osseointegration. The combination of robotic-assisted surgery, personalized treatment planning, and advanced implant materials is driving innovation throughout the artificial hip and knee joints industry, enabling more precise and durable joint replacement solutions for patients with degenerative joint diseases and mobility disorders.

Artificial Hip and Knee Joints Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Artificial Hip and Knee Joints market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Zimmer Biomet Holdings Inc., Stryker Corporation, Johnson & Johnson MedTech (DePuy Synthes), Smith+Nephew, Enovis (DJO Global), Medacta International, Exactech, Inc. (Advita Ortho), B. Braun SE (Aesculap), MicroPort Scientific Corporation, Conformis (Restor3d). The Artificial Hip and Knee Joints market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Artificial Hip and Knee Joints industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Artificial Hip and Knee Joints Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Artificial Hip and Knee Joints companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Artificial Hip and Knee Joints markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Artificial Hip and Knee Joints Market Competitive Benchmarking and Company Analysis

Leading companies in Artificial Hip and Knee Joints industry include- Zimmer Biomet Holdings Inc., Stryker Corporation, Johnson & Johnson MedTech (DePuy Synthes), Smith+Nephew, Enovis (DJO Global), Medacta International, Exactech, Inc. (Advita Ortho), B. Braun SE (Aesculap), MicroPort Scientific Corporation, Conformis (Restor3d). The Artificial Hip and Knee Joints market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Artificial Hip and Knee Joints Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Artificial Hip and Knee Joints market remains one of the strongest-performing segments in the country.
The US Artificial Hip and Knee Joints Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Artificial Hip and Knee Joints market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Artificial Hip and Knee Joints industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Artificial Hip and Knee Joints markets

Canada's strong Artificial Hip and Knee Joints sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Artificial Hip and Knee Joints market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Artificial Hip and Knee Joints Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Artificial Hip and Knee Joints market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Artificial Hip and Knee Joints population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Artificial Hip and Knee Joints industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Artificial Hip and Knee Joints market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Artificial Hip and Knee Joints sales through 2034

France Artificial Hip and Knee Joints companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Artificial Hip and Knee Joints Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Artificial Hip and Knee Joints distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Artificial Hip and Knee Joints Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Artificial Hip and Knee Joints market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Artificial Hip and Knee Joints industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Artificial Hip and Knee Joints industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Artificial Hip and Knee Joints Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Artificial Hip and Knee Joints market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Artificial Hip and Knee Joints market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Artificial Hip and Knee Joints Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Artificial Hip and Knee Joints Market Segmentation

By Product
Knee Reconstructive Implants
Hip Reconstructive Implants
By Procedure
Total Joint Arthroplasty
Partial / Hemi-Arthroplasty
Revision Joint Arthroplasty
Cemented Fixation Systems
Cementless / Press-Fit Fixation Systems
By Material & Bearing Surface
Ceramic-on-Polyethylene
Ceramic-on-Ceramic
Metal-on-Polyethylene
3D-Printed Porous Titanium / Metallic Scaffolds
By Surgical Approach
Traditional Open Joint Surgery
Minimally Invasive Surgery
Robotic-Assisted Surgery
By End-User
Hospitals & Tertiary Surgery Centers
Ambulatory Surgical Centers
Orthopedic Clinics & Private Practices

Top Companies in Artificial Hip and Knee Joints Industry

Zimmer Biomet Holdings Inc.
Stryker Corporation
Johnson & Johnson MedTech (DePuy Synthes)
Smith+Nephew
Enovis (DJO Global)
Medacta International
Exactech, Inc. (Advita Ortho)
B. Braun SE (Aesculap)
MicroPort Scientific Corporation
Conformis (Restor3d)

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025